Novaflow
June 25, 2026
Theater 2
Type: Company Presentation
Focus Area:
AI and Digital Health
Novaflow is an AI-powered bioinformatics platform that automates and accelerates genomic and multi-omics analysis for academic labs, biotech, and pharma. Our SaaS platform provides end-to-end pipeline development, execution, and data management - from raw data to biological insight - across modern omics data types. While we support standard workflows like bulk and single-cell RNA-seq, Novaflow specializes in complex, emerging data types that most solutions cannot handle, including spatial transcriptomics, multiplexed tissue imaging, and integrative pathway analysis. Our platform also solves the infrastructure challenges that slow research: large-scale data processing, storage, and compute, all in one place. Novaflow is trusted by leading academic medical centers and pharma R&D teams to reduce analysis timelines from weeks to hours while maintaining reproducibility and scientific rigor. We are a one-stop bioinformatics solution built for the hardest problems in modern biology.
Company HQ City:
San Francisco
Company HQ State:
CA
Company HQ Country:
United States
Year Founded:
2025
Lead Product in Development:
Novaflow - an AI-powered bioinformatics SaaS platform that automates analysis of genomic, multi-omics, spatial transcriptomics, and multiplexed tissue imaging data, taking research teams from raw data to biological insight
CEO
Amulya Balakrishnan
Development Phase of Lead Product
Other/Not Applicable
When you expect your next catalyst update?
October 2026
What is your next catalyst (value inflection) update?
Signing additional enterprise and pharma R&D contracts and growing to $6M ARR, positioning Novaflow for a Series A.
Primary Speaker




